Insiders Fulcrum Therapeutics, Inc.

Equities

FULC

US3596161097

Real-time Estimate Cboe BZX Other stock markets 03:05:47 2024-06-11 pm EDT			5-day change	1st Jan Change
7.63 ^USD	-6.50%		-6.76%	+12.44%

Jun. 10	Transcript : Fulcrum Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:00 AM
May. 20	Cantor Fitzgerald Initiates Fulcrum Therapeutics at Overweight Rating With $23 Price Target	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Fulcrum Therapeutics Appoints Patrick Horn as Chief Medical Officer	Mar. 18	MT
Fulcrum Therapeutics, Inc. Announces Executive Changes	Mar. 18	CI
GSK: Dr Jeannie Lee joins the Board of Directors	Feb. 29	CF
Spero Therapeutics Appoints Esther Rajavelu Chief Financial Officer	Nov. 01	MT
Fulcrum Therapeutics, Inc. Announces Resignation of Mel Hayes as Chief Operating Officer	23-10-02	CI
Fulcrum Therapeutics Names Alan Musso Chief Financial Officer	23-08-03	MT
Fulcrum Therapeutics, Inc. Appoints Alan A. Musso as Chief Financial Officer, Effective August 7, 2023	23-08-03	CI
Fulcrum Therapeutics, Inc. Announces Management Changes	23-05-15	CI
Fulcrum Therapeutics, Inc. Chief Executive Officer Changes	23-05-15	CI
Fulcrum Therapeutics Appoints Alex C. Sapir as President, Chief Executive	23-05-15	MT
Fulcrum Therapeutics Finance Chief Esther Rajavelu Resigns	23-04-05	MT
Fulcrum Therapeutics, Inc. Announces Resignation of Esther Rajavelu as Treasurer, Effective April 21, 2023	23-04-05	CI
Fulcrum Therapeutics, Inc. Announces Resignation of Esther Rajavelu as Chief Financial Officer, Effective April 21, 2023	23-04-05	CI
Fulcrum Therapeutics Chief Medical Officer Santiago Arroyo Resigns; Shares Drop	23-03-09	MT
Fulcrum Therapeutics, Inc. Announces Executive Changes	23-03-09	CI
Fulcrum Therapeutics CEO Bryan Stuart Steps Down, Robert Gould Named Interim CEO	23-01-04	MT
Fulcrum Therapeutics, Inc. Announces Resignation of Bryan Stuart from the Board of Directors	23-01-04	CI
Fulcrum Therapeutics, Inc. Announces CEO Transition	23-01-04	CI
Fulcrum Therapeutics Appoints Santiago Arroyo as Chief Medical Officer, Jeff Jacobs as Chief Scientific Officer	22-11-08	MT
Fulcrum Therapeutics, Inc. Announces Management Changes	22-11-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Fulcrum Therapeutics, Inc.

Equities

FULC

US3596161097

Insiders

Filters